Journal of the Pakistan Medical Association (Oct 2022)
The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis
Abstract
Not required
Journal of the Pakistan Medical Association (Oct 2022)
Not required